Buy or sell Truveris stock pre IPO via an EquityZen fund
Truveris is a technology company driving transparency, access and lower costs across the prescription drug ecosystem.
About Truveris Stock
Truveris brings transparency to the prescription drug ecosystem through data-driven innovations. Truveris’ platform offers customers – from the individual patient to employers, retailers, pharmacy benefits stakeholders, and manufacturers – the data and insights they need to effectively and efficiently manage rising costs and market access challenges. Based in Manhattan, Truveris is backed by Canaan Partners, New Leaf Venture Partners, Tribeca Venture Partners, New Atlantic Ventures and First Round Capital.
Chief Pharmacy Officer
Chief Financial Officer